Alleinige IF-RT bleibt Goldstandard beim nodulären lymphozytenprädominanten Hodgkin-Lymphom im Stadium IA

Saved in:
Bibliographic Details
Published in:Strahlentherapie und Onkologie 2016-06, Vol.192 (6), p.428-430
Main Authors: Pilz, Karoline, Jentsch, Christina, Krause, Mechthild
Format: Article
Language:ger
Subjects:
Literatur Kommentiert
Medicine
Medicine & Public Health
Oncology
Radiotherapy
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c155y-82083e271bec0b184a7d7bab8a59633ecc5fde901022eb7127694bbd0318acbd3
container_end_page 430
container_issue 6
container_start_page 428
container_title Strahlentherapie und Onkologie
container_volume 192
creator Pilz, Karoline
Jentsch, Christina
Krause, Mechthild
description
doi_str_mv 10.1007/s00066-016-0975-y
format article
fullrecord <record><control><sourceid>crossref_sprin</sourceid><recordid>TN_cdi_crossref_primary_10_1007_s00066_016_0975_y</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1007_s00066_016_0975_y</sourcerecordid><originalsourceid>FETCH-LOGICAL-c155y-82083e271bec0b184a7d7bab8a59633ecc5fde901022eb7127694bbd0318acbd3</originalsourceid><addsrcrecordid>eNp9kMtKAzEUhoMoWKsP4C4vED2ZWybLUuwFCoJWcBeSSVqnZjIlmS7Gp3HRJ2lfzNS6dnE4_PB_h8OH0D2FBwrAHgMAFAUBGoeznPQXaECzlMfE3y_RACjjhNG8vEY3IWwgFjOeDZAdWWtqV68Nnk_IyxKrGFWHp63VoZNOS6-xMnWDXat39rj3xmHbN9uP9qvvjNv64163Te2kiwnPWr3-rB1Z_DYaHLnXTup61xy-56NbdLWSNpi7vz1Eb5On5XhGFs_T-Xi0IBXN856UCZSpSRhVpgJFy0wyzZRUpcx5kaamqvKVNhwoJIlRjCas4JlSGlJaykrpdIjo-W7l2xC8WYmtrxvpe0FBnHSJsy4RLYiTLtFHJjkzIXbd2nixaXfexTf_gX4Aablyjw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Alleinige IF-RT bleibt Goldstandard beim nodulären lymphozytenprädominanten Hodgkin-Lymphom im Stadium IA</title><source>Springer Link</source><creator>Pilz, Karoline ; Jentsch, Christina ; Krause, Mechthild</creator><creatorcontrib>Pilz, Karoline ; Jentsch, Christina ; Krause, Mechthild</creatorcontrib><identifier>ISSN: 0179-7158</identifier><identifier>EISSN: 1439-099X</identifier><identifier>DOI: 10.1007/s00066-016-0975-y</identifier><language>ger</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Literatur Kommentiert ; Medicine ; Medicine &amp; Public Health ; Oncology ; Radiotherapy</subject><ispartof>Strahlentherapie und Onkologie, 2016-06, Vol.192 (6), p.428-430</ispartof><rights>Springer-Verlag Berlin Heidelberg 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c155y-82083e271bec0b184a7d7bab8a59633ecc5fde901022eb7127694bbd0318acbd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Pilz, Karoline</creatorcontrib><creatorcontrib>Jentsch, Christina</creatorcontrib><creatorcontrib>Krause, Mechthild</creatorcontrib><title>Alleinige IF-RT bleibt Goldstandard beim nodulären lymphozytenprädominanten Hodgkin-Lymphom im Stadium IA</title><title>Strahlentherapie und Onkologie</title><addtitle>Strahlenther Onkol</addtitle><subject>Literatur Kommentiert</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Oncology</subject><subject>Radiotherapy</subject><issn>0179-7158</issn><issn>1439-099X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp9kMtKAzEUhoMoWKsP4C4vED2ZWybLUuwFCoJWcBeSSVqnZjIlmS7Gp3HRJ2lfzNS6dnE4_PB_h8OH0D2FBwrAHgMAFAUBGoeznPQXaECzlMfE3y_RACjjhNG8vEY3IWwgFjOeDZAdWWtqV68Nnk_IyxKrGFWHp63VoZNOS6-xMnWDXat39rj3xmHbN9uP9qvvjNv64163Te2kiwnPWr3-rB1Z_DYaHLnXTup61xy-56NbdLWSNpi7vz1Eb5On5XhGFs_T-Xi0IBXN856UCZSpSRhVpgJFy0wyzZRUpcx5kaamqvKVNhwoJIlRjCas4JlSGlJaykrpdIjo-W7l2xC8WYmtrxvpe0FBnHSJsy4RLYiTLtFHJjkzIXbd2nixaXfexTf_gX4Aablyjw</recordid><startdate>20160601</startdate><enddate>20160601</enddate><creator>Pilz, Karoline</creator><creator>Jentsch, Christina</creator><creator>Krause, Mechthild</creator><general>Springer Berlin Heidelberg</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20160601</creationdate><title>Alleinige IF-RT bleibt Goldstandard beim nodulären lymphozytenprädominanten Hodgkin-Lymphom im Stadium IA</title><author>Pilz, Karoline ; Jentsch, Christina ; Krause, Mechthild</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c155y-82083e271bec0b184a7d7bab8a59633ecc5fde901022eb7127694bbd0318acbd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>ger</language><creationdate>2016</creationdate><topic>Literatur Kommentiert</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Oncology</topic><topic>Radiotherapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pilz, Karoline</creatorcontrib><creatorcontrib>Jentsch, Christina</creatorcontrib><creatorcontrib>Krause, Mechthild</creatorcontrib><collection>CrossRef</collection><jtitle>Strahlentherapie und Onkologie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pilz, Karoline</au><au>Jentsch, Christina</au><au>Krause, Mechthild</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Alleinige IF-RT bleibt Goldstandard beim nodulären lymphozytenprädominanten Hodgkin-Lymphom im Stadium IA</atitle><jtitle>Strahlentherapie und Onkologie</jtitle><stitle>Strahlenther Onkol</stitle><date>2016-06-01</date><risdate>2016</risdate><volume>192</volume><issue>6</issue><spage>428</spage><epage>430</epage><pages>428-430</pages><issn>0179-7158</issn><eissn>1439-099X</eissn><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><doi>10.1007/s00066-016-0975-y</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0179-7158
ispartof Strahlentherapie und Onkologie, 2016-06, Vol.192 (6), p.428-430
issn 0179-7158
1439-099X
language ger
recordid cdi_crossref_primary_10_1007_s00066_016_0975_y
source Springer Link
subjects Literatur Kommentiert
Medicine
Medicine & Public Health
Oncology
Radiotherapy
title Alleinige IF-RT bleibt Goldstandard beim nodulären lymphozytenprädominanten Hodgkin-Lymphom im Stadium IA
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T13%3A33%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref_sprin&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Alleinige%20IF-RT%20bleibt%20Goldstandard%20beim%20nodul%C3%A4ren%20lymphozytenpr%C3%A4dominanten%20Hodgkin-Lymphom%20im%20Stadium%C2%A0IA&rft.jtitle=Strahlentherapie%20und%20Onkologie&rft.au=Pilz,%20Karoline&rft.date=2016-06-01&rft.volume=192&rft.issue=6&rft.spage=428&rft.epage=430&rft.pages=428-430&rft.issn=0179-7158&rft.eissn=1439-099X&rft_id=info:doi/10.1007/s00066-016-0975-y&rft_dat=%3Ccrossref_sprin%3E10_1007_s00066_016_0975_y%3C/crossref_sprin%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c155y-82083e271bec0b184a7d7bab8a59633ecc5fde901022eb7127694bbd0318acbd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true